News

• SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Five Prime Therapeutics, Inc. Buyout
  03/04/2021 / 19:43 - GlobeNewswire
•  
• FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
  03/04/2021 / 18:02 - GlobeNewswire
•  
• Entera Bio To Present At The H.C. Wainwright Global Life Sciences Conference
  03/04/2021 / 14:30 - GlobeNewswire
•  
• Orphazyme appoints Christophe Bourdon as Chief Executive Officer
  03/01/2021 / 07:00 - GlobeNewswire
•  
• Cytokinetics Reports Fourth Quarter 2020 Financial Results
  02/25/2021 / 22:00 - GlobeNewswire
•  
• Entera Bio Announces Publication of Phase 2 Hypoparathyroidism Study in the Journal of Bone and Mineral Research
  02/25/2021 / 14:30 - GlobeNewswire
•  
• CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
  02/24/2021 / 22:15 - GlobeNewswire
•  
• CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences
  02/22/2021 / 14:00 - GlobeNewswire
•  
• CytomX Therapeutics Announces New Employment Inducement Grant
  02/19/2021 / 14:00 - GlobeNewswire
•  
• Adverum Appoints Christopher J. DeRespino as Chief Business Officer
  02/18/2021 / 22:00 - GlobeNewswire
•  
• Monopar Expands Clinical Team with Appointment of Laura Kelly as Director of Clinical Operations
  02/18/2021 / 13:00 - GlobeNewswire
•  
• CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
  02/17/2021 / 14:00 - GlobeNewswire
•  
• Royalty Pharma Reports Q4 2020 and Full-Year Results
  02/17/2021 / 13:00 - GlobeNewswire
•  
• Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
  02/17/2021 / 12:30 - GlobeNewswire
•  
• Resilinc Launches Predictive Purchase Order (PO) On-Time Delivery Solution
  02/16/2021 / 16:00 - GlobeNewswire